Preliminary safety evaluation and probiotic potential of a tempeh-derived lactic acid bacteria consortium in Wistar rats
Notulae Scientia Biologicae · 10.06.2026 · 18 (2) · 12879
DOI: 10.55779/nsb18212879 ↗Kurz gefasst
Fachartikel in der Zeitschrift Notulae Scientia Biologicae, online erschienen am 10.06.2026. Verfasst von Siti Nur Azizah und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The lactic acid bacteria (LAB) consortium isolated from tempeh produced in Jember, East Java, Indonesia, represents a promising probiotic candidate. This study aimed to evaluate the preliminary safety and probiotic potential of the LAB consortium administered at high doses for 28 days in Wistar rats. This study employed a true experimental design consisting of four groups: healthy (P1), milk (P2), LAB consortium at a dose of 10¹¹ CFU mL⁻¹ rat⁻¹ day⁻¹ (P3), and LAB consortium at a dose of 2 ×10¹¹ CFU mL⁻¹ rat⁻¹ day⁻¹ (P4). Throughout the experiment, feed intake, body weight, and fecal consistency were monitored daily and subsequently analyzed. On day 29, blood samples were collected for hematological and serum biochemical analyses, whereas ileum, colon, and fecal samples were collected for histological and microbiological examinations. The results demonstrated that high-dose LAB consortium treatment (P4) did not produce any effects on general health status, organ weights index, hematological, clinical chemistry, or ileum histoanatomy, all of which were comparable to those observed in the healthy group (P1). Administration of the LAB consortium (P4) also contributed to an increase in the LAB population in the colon, reaching 10⁸ CFU mL⁻¹, which was higher than that observed in the other groups. The fecal bacterial profile revealed that Shigella was undetectable in group P4. The population of Escherichia coli remained relatively stable across all groups, while Salmonella was absent in all. Therefore, administration of the LAB consortium provides preliminary evidence of safety and indicates its potential for development as a probiotic candidate.
Zitieren
APA
Azizah, S. N., Rosida, R., & Febiaocti, R. Y. (2026). Preliminary safety evaluation and probiotic potential of a tempeh-derived lactic acid bacteria consortium in Wistar rats. Notulae Scientia Biologicae, 18(2), 12879. https://doi.org/10.55779/nsb18212879
Vancouver
Azizah SN, Rosida R, Febiaocti RY. Preliminary safety evaluation and probiotic potential of a tempeh-derived lactic acid bacteria consortium in Wistar rats. Notulae Scientia Biologicae. 2026;18(2):12879. doi:10.55779/nsb18212879
BibTeX
@article{Azizah2026,
author = {Azizah, Siti Nur and Rosida, Rosida and Febiaocti, Rizka Yolanda},
title = {Preliminary safety evaluation and probiotic potential of a tempeh-derived lactic acid bacteria consortium in Wistar rats},
journal = {Notulae Scientia Biologicae},
year = {2026},
volume = {18},
number = {2},
pages = {12879},
doi = {10.55779/nsb18212879}
}
EUVIMED